Request for Covid-19 Impact Assessment of this Report

Healthcare

Buprenorphine Hydrochloride Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

  • 99S4096397
  • 94 Pages
  • November 2020
  • Healthcare
Download Sample    Get Discount   
 
Summary

Further key aspects of the report indicate that:

Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology

Chapter 2: Global Industry Summary

Chapter 3: Market Dynamics

Chapter 4: Global Market Segmentation by region, type and End-Use

Chapter 5: North America Market Segmentation by region, type and End-Use

Chapter 6: Europe Market Segmentation by region, type and End-Use

Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use

Chapter 8: South America Market Segmentation by region, type and End-Use

Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.

Chapter 10: Market Competition by Companies

Chapter 11: Market forecast and environment forecast.

Chapter 12: Industry Summary

.

The global Buprenorphine Hydrochloride market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Buprenorphine Hydrochloride market segmented into

Analgesic

Capsule

Based on the end-use, the global Buprenorphine Hydrochloride market classified into

Analgesic

Opioid Antagonist

Based on geography, the global Buprenorphine Hydrochloride market segmented into

North America [U.S., Canada, Mexico]

Europe [Germany, UK, France, Italy, Rest of Europe]

Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]

South America [Brazil, Argentina, Rest of Latin America]

Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are

Siegfried

Sanofi

Johnson Matthey

Mallinckrodt

Noramco

Unichemlabs

Arevipharma

Resonance-labs

Sun Pharma

Rusan Pharma

Micro Orgo Chem

Faranshimi

Table of Contents

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL BUPRENORPHINE HYDROCHLORIDE INDUSTRY

2.1 Summary about Buprenorphine Hydrochloride Industry

2.2 Buprenorphine Hydrochloride Market Trends

2.2.1 Buprenorphine Hydrochloride Production & Consumption Trends

2.2.2 Buprenorphine Hydrochloride Demand Structure Trends

2.3 Buprenorphine Hydrochloride Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Tablet

4.2.2 Capsule

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Analgesic

4.3.2 Opioid Antagonist

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Tablet

5.2.2 Capsule

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Analgesic

5.3.2 Opioid Antagonist

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Tablet

6.2.2 Capsule

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Analgesic

6.3.2 Opioid Antagonist

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Tablet

7.2.2 Capsule

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Analgesic

7.3.2 Opioid Antagonist

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Tablet

8.2.2 Capsule

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Analgesic

8.3.2 Opioid Antagonist

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Tablet

9.2.2 Capsule

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Analgesic

9.3.2 Opioid Antagonist

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Siegfried

10.1.2 Sanofi

10.1.3 Johnson Matthey

10.1.4 Mallinckrodt

10.1.5 Noramco

10.1.6 Unichemlabs

10.1.7 Arevipharma

10.1.8 Resonance-labs

10.1.9 Sun Pharma

10.1.10 Rusan Pharma

10.1.11 Micro Orgo Chem

10.1.12 Faranshimi

10.2 Buprenorphine Hydrochloride Sales Date of Major Players (2017-2020e)

10.2.1 Siegfried

10.2.2 Sanofi

10.2.3 Johnson Matthey

10.2.4 Mallinckrodt

10.2.5 Noramco

10.2.6 Unichemlabs

10.2.7 Arevipharma

10.2.8 Resonance-labs

10.2.9 Sun Pharma

10.2.10 Rusan Pharma

10.2.11 Micro Orgo Chem

10.2.12 Faranshimi

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

List of Table

1.Table Buprenorphine Hydrochloride Product Type Overview

2.Table Buprenorphine Hydrochloride Product Type Market Share List

3.Table Buprenorphine Hydrochloride Product Type of Major Players

4.Table Brief Introduction of Siegfried

5.Table Brief Introduction of Sanofi

6.Table Brief Introduction of Johnson Matthey

7.Table Brief Introduction of Mallinckrodt

8.Table Brief Introduction of Noramco

9.Table Brief Introduction of Unichemlabs

10.Table Brief Introduction of Arevipharma

11.Table Brief Introduction of Resonance-labs

12.Table Brief Introduction of Sun Pharma

13.Table Brief Introduction of Rusan Pharma

14.Table Brief Introduction of Micro Orgo Chem

15.Table Brief Introduction of Faranshimi

16.Table Products & Services of Siegfried

17.Table Products & Services of Sanofi

18.Table Products & Services of Johnson Matthey

19.Table Products & Services of Mallinckrodt

20.Table Products & Services of Noramco

21.Table Products & Services of Unichemlabs

22.Table Products & Services of Arevipharma

23.Table Products & Services of Resonance-labs

24.Table Products & Services of Sun Pharma

25.Table Products & Services of Rusan Pharma

26.Table Products & Services of Micro Orgo Chem

27.Table Products & Services of Faranshimi

28.Table Market Distribution of Major Players

29.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

30.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

31.Table Global Buprenorphine Hydrochloride Market Forecast (Million USD) by Region 2021f-2026f

32.Table Global Buprenorphine Hydrochloride Market Forecast (Million USD) Share by Region 2021f-2026f

33.Table Global Buprenorphine Hydrochloride Market Forecast (Million USD) by Demand 2021f-2026f

34.Table Global Buprenorphine Hydrochloride Market Forecast (Million USD) Share by Demand 2021f-2026f

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950